Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Michalsen also believes people will see more benefits from RFID in the pharmaceutical industry. He admitted some companies remain reluctant due to standardization issues in this market. “I think there’s been a debate going on about which frequency is going to be utilized. Is it going to be HF? Is it going to be UHF? Is it going to be a combination? There’s still work being done on trying to standardize that. And until that happens, I don’t think companies are going to be so willing to commit to infrastructure and all the things they need to make it work in their system. But it’s coming and that’s really what’s going to be the next necessary step for RFID to really become cost effective,” he said.
0 Comments
View Comments
Related Content
Comments